Effects of chronic treatment with compound-326 on PD markers and gene expression in WAT in DIO mice. by Hiroaki Yashiro (2231686)

Both the HRM and the HTM reproduce the key features of medfly mortality pattern: (i) increase, (ii) local maximum, (iii) U-shape, (iv) second local maximum, higher than the first o... by Yann Le Cunff (102173)

Epigenetic regulator expression in individual human blastocysts by qPCR (n = 12 replicates for each group). by Blair R. McCallie (2822252)

ODE modeling of WNT5A-EGF/AR signaling and experimental validation. by Zhiwei Ji (493628)

“…<p>(<b>A)</b> The effect of WNT5A on 22RV1 cell viability. …”

Parasite viability 5 days after the end of the infection. by Elaine Carvalho de Oliveira (11630455)

Schematic representation of the effects of stepwise bromination of the benzene ring of benzotriazole (Bt), including interdependence of the molecular volume (A) and pK_a (B) of the products with their IC₅₀ for inhibition of protein kinase CK2α: (a) Green arrows follow sequential bromination of the central vicinal C(5)/C(6) atoms, leading to a moderate decrease of pK_a and a large decrease in IC₅₀; (b) Red arrows illustrate the lesser effects of bromination of the peripheral C(4)/C(7) atoms, resulting in a significant decrease of pK_a, with virtually no gain in inhibitory activity; (c) Black lines link products with the same number of bromine atoms, but substantially differing in pK_a and IC₅₀, culminating in the di- and tri-brominated derivatives with inhibitory activities comparable to that of TBBt. by Romualda Wąsik (119538)

Effects of chronic treatment with compound-326 on plasma glucose and insulin during an OGTT, and HOMA-IR in DIO mice. by Hiroaki Yashiro (2231686)

Effects of chronic treatment with compound-326 on BW, calorie intake, and fat mass in DIO mice. by Hiroaki Yashiro (2231686)

The Associations Between SDI and iNTS across 21 GBD Regions. A. by Yunjuan He (7107446)

Proline catabolism is induced by proline in a Put3-dependent and -independent manner. by Fitz Gerald S. Silao (9384713)

Effects of chronic treatment with compound-326 on BW, calorie intake, and blood PD markers in DIO mice. by Hiroaki Yashiro (2231686)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Discovery of Novel <i>N</i>‑Hydroxy-1,2,4-oxadiazole-5-formamides as ASM Direct Inhibitors for the Treatment of Atherosclerosis by Kan Yang (49193)

Comparison of the protein level and fluorescent intensity between EGFP and sfGFP expressed from the <i>C. merolae</i> genome. by Nobuko Sumiya (648113)

Basal transcriptional activities of the upstream region of <i>CMJ101C orf</i> at lower temperatures in the stable transformants. by Nobuko Sumiya (648113)

Duration-dependent effect of 50°C heat shock on the mRNA and protein levels in the stable transformants. by Nobuko Sumiya (648113)

Optimum temperature for heat shock inducible expression in the stable transformants. by Nobuko Sumiya (648113)